Pulmonx Corporation (LUNG) NASDAQ

2.28

+0.06(+2.70%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap265.56M
Enterprise Value251.13M
P/E Ratio-1.61
PEG Ratio-2.32
Price/Sales Ratio1.04
Price/Book Ratio1.33
Enterprise/Revenue0.83
Enterprise/EBITDA-1.26

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.63
Operating Margin-0.65

Management Effectiveness

Return On Assets-0.39
Return On Equity-0.7

Income Statement

Revenue83.79M
Revenue/Share2.25
Gross Profit62M
EBITDA-50.79M
Net Income-56.39M
Diluted EPS-1.44

Balance Sheet

Total Cash76.55M
Total Cash/Share2.1
Total Debt56.56M
Total Debt/Equity0.82
Current Ratio5.35
Book Value Per Share1.72

Price History

52-Week Change-62.99
52-Week High9.37
52-Week Low1.31
Moving Average 50 Days1.88
Moving Average 200 Days2.99

Statistics

Average Volume2.67M
Shares Outstanding41.24M
% Held by Institutions79.21

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A